(Q43752615)

26 November 2017

title

Population pharmacokinetic study of memantine: effects of clinical and genetic factors (English)

1 reference

Panteleimon Giannakopoulos

26 November 2017

author

11

1 reference

26 November 2017

13

1 reference

26 November 2017

12

Armin von Gunten

0 references

Stephan Eyer

object named as

Stephan Eyer

4

0 references

Monia Guidi

object named as

Monia Guidi

2

0 references

Chin B. Eap

object named as

Chin B Eap

14

0 references

author name string

Muriel Noetzli

1

1 reference

26 November 2017

Karsten Ebbing

3

1 reference

26 November 2017

Laurence Wilhelm

5

1 reference

26 November 2017

Agnès Michon

6

1 reference

26 November 2017

Valérie Thomazic

7

1 reference

26 November 2017

Abdel-Messieh Alnawaqil

8

1 reference

26 November 2017

Sophie Maurer

9

1 reference

26 November 2017

Serge Zumbach

10

1 reference

26 November 2017

Armin von Gunten

12

1 reference

26 November 2017

publication date

1 March 2013

1 reference

Clinical Pharmacokinetics

26 November 2017

published in

1 reference

26 November 2017

volume

52

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

211-223

1 reference

Memantine in dementia: a review of the current evidence

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Pharmacogenomics of membrane transporters: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Role of organic cation transporters in drug-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Clinical Pharmacokinetics of Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Current understanding of the pharmacogenomics of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Regulation of hepatic transporters by xenobiotic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Genetic predictors of interindividual variability in hepatic CYP3A4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Organic cation transporters modulate the uptake and cytotoxicity of picoplatin, a third-generation platinum analogue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Memantine pharmacotherapy: a naturalistic study using a population pharmacokinetic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Pharmacokinetic study of memantine in healthy and renally impaired subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Regulatory role of testosterone in organic cation transport: in vivo and in vitro studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: a single-center, multiple-dose, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Influence of urine pH and urinary flow on the renal excretion of memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Implications of genetic polymorphisms in drug transporters for pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Long-term changes in cyclosporine pharmacokinetics after renal transplantation in children: evidence for saturable presystemic metabolism and effect of NR1I2 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Identification of polymorphisms in the 3'-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0032-2

Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine

21 January 2018

1 reference

12 December 2020

Simultaneous Determination of Antidementia Drugs in Human Plasma for Therapeutic Drug Monitoring

1 reference

12 December 2020

ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir

1 reference

12 December 2020

Effect of pregnane X receptor ligand on pharmacokinetics of substrates of organic cation transporter Oct1 in rats

1 reference

12 December 2020

10.1007/S40262-013-0032-2

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

1047015988

0 references

1 reference